Subscribe Us

header ads

Recents

header ads

Baby Food Market Size, Growth, Demands Outlook and Forecasts to 2030

Precedence Research - February 02, 2023

According to the research report, the global baby food market size is expected to touch USD 120 Billion by 2030, from USD 77.97 Billion in 2022, growing with a significant CAGR of 5.54% from 2022 to 2030. 

Baby Food Market Size, Report 2021 to 2030

The baby food report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global baby food in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global baby food market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global baby food during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1710

 Report Scope of the Baby Food Market

Report CoverageDetails
Market Size by 2030USD 120 Billion
Growth Rate from 2022 to 2030

CAGR of 5.54%

Largest MarketAsia Pacific
Online Distribution Channel Segment Growth Rate13.2% from 2022 to 2030
Base Year2021
Forecast Period2022 to 2030
Segments CoveredCategory, Types, Distribution Channel, Ingredients, Formulation, Health Benefit, Geography

This study covers a detailed segmentation of the global baby food market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global baby food market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • Nestlé (Gerber Products Company)
  • Danone S.A.
  • Reckitt Benckiser (Mead Johnson & Company, LLC)
  • Abbott
  • Feihe International Inc.
  • Fries land Campina
  • Bellamy's Organic
  • Kraft Heinz
  • HiPP GmbH & Co. Vertrieb KG
  • Perrigo
  • Arla Food

Market Segmentation

 By Category

  •  Organic
  • Conventional

By Types

  • Milk Formula
  • Dried
  • Ready-to-Feed
  •  Other

By Distribution Channel

  • Drugstores/ Pharmacies
  • Supermarkets/Hypermarkets
  • Convenience Store
  • Online Channels
  • Other Distribution Channels

By Ingredients

  • Fats and Oils
  • Lactose
  • Protein
  • Flour
  • Flavour Enhancer
  • Vitamins & Minerals
  • Others

By Formulation

  • Powder
  • Liquid

By Health Benefit

  • Brain & Eye Development
  • Muscular Growth
  • Bones & Teeth Development
  • Blood Enhancement
  • Nervous System
  • Vascular System
  • Body Energy
  • Other

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global baby food report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global baby food market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Health Benefit Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Baby Food Market 

5.1. COVID-19 Landscape: Baby Food Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Baby Food Market, By Category Type

8.1. Baby Food Market, by Category Type, 2022-2030

8.1.1. Organic

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Conventional

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Baby Food Market, By Types

9.1. Baby Food Market, by Types Type, 2022-2030

9.1.1. Milk Formula

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Dried

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Ready-to-Feed

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Baby Food Market, By Ingredients Type 

10.1. Baby Food Market, by Ingredients Type, 2022-2030

10.1.1. Fats and Oils

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Lactose

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Protein

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Flour

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Flavour Enhancer

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.6. Vitamins & Minerals

10.1.6.1. Market Revenue and Forecast (2017-2030)

10.1.7. Others

10.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Baby Food Market, By Formulation Type

11.1. Baby Food Market, by Formulation Type, 2022-2030

11.1.1. Powder

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Liquid

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Baby Food Market, By Distribution Channel

12.1. Baby Food Market, by Distribution Channel, 2022-2030

12.1.1. Drugstores/ Pharmacies

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Supermarkets/Hypermarkets

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Online Channels

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Convenience Store

12.1.4.1. Market Revenue and Forecast (2017-2030)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Baby Food Market, By Health Benefit

13.1. Baby Food Market, by Health Benefit Type, 2022-2030

13.1.1. Brain & Eye Development

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Muscular Growth

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Bones & Teeth Development

13.1.3.1. Market Revenue and Forecast (2017-2030)

13.1.4. Blood Enhancement

13.1.4.1. Market Revenue and Forecast (2017-2030)

13.1.5. Nervous System

13.1.5.1. Market Revenue and Forecast (2017-2030)

13.1.6. Vascular System

13.1.6.1. Market Revenue and Forecast (2017-2030)

13.1.7. Body Energy

13.1.7.1. Market Revenue and Forecast (2017-2030)

13.1.8. Others

13.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Baby Food  Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Category (2017-2030)

14.1.2. Market Revenue and Forecast, by Types (2017-2030)

14.1.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.1.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.1.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.1.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Category (2017-2030)

14.1.7.2. Market Revenue and Forecast, by Types (2017-2030)

14.1.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.1.7.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.1.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.1.8.1. Market Revenue and Forecast, by Health Benefit (2017-2030) 

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Category (2017-2030)

14.1.9.2. Market Revenue and Forecast, by Types (2017-2030)

14.1.9.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.1.9.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.1.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.1.11. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Category (2017-2030)

14.2.2. Market Revenue and Forecast, by Types (2017-2030)

14.2.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.2.4. Market Revenue and Forecast, by Formulation (2017-2030) 

14.2.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.2.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Category (2017-2030)

14.2.8.2. Market Revenue and Forecast, by Types (2017-2030)

14.2.8.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.2.9. Market Revenue and Forecast, by Formulation (2017-2030) 

14.2.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.2.10.1. Market Revenue and Forecast, by Health Benefit (2017-2030) 

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Category (2017-2030)

14.2.11.2. Market Revenue and Forecast, by Types (2017-2030)

14.2.11.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.2.12. Market Revenue and Forecast, by Formulation (2017-2030)

14.2.13. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.2.14. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Category (2017-2030)

14.2.15.2. Market Revenue and Forecast, by Types (2017-2030)

14.2.15.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.2.15.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.2.16. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.2.16.1. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Category (2017-2030)

14.2.17.2. Market Revenue and Forecast, by Types (2017-2030)

14.2.17.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.2.17.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.2.18. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.2.18.1. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Category (2017-2030)

14.3.2. Market Revenue and Forecast, by Types (2017-2030)

14.3.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.3.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.3.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.3.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Category (2017-2030)

14.3.7.2. Market Revenue and Forecast, by Types (2017-2030)

14.3.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.3.7.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.3.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.3.9. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Category (2017-2030)

14.3.10.2. Market Revenue and Forecast, by Types (2017-2030)

14.3.10.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.3.10.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.3.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.3.11.1. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Category (2017-2030)

14.3.12.2. Market Revenue and Forecast, by Types (2017-2030)

14.3.12.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.3.12.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.3.12.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.3.12.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Category (2017-2030)

14.3.13.2. Market Revenue and Forecast, by Types (2017-2030)

14.3.13.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.3.13.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.3.13.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.3.13.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Category (2017-2030)

14.4.2. Market Revenue and Forecast, by Types (2017-2030)

14.4.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.4.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.4.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.4.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Category (2017-2030)

14.4.7.2. Market Revenue and Forecast, by Types (2017-2030)

14.4.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.4.7.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.4.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.4.9. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Category (2017-2030)

14.4.10.2. Market Revenue and Forecast, by Types (2017-2030)

14.4.10.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.4.10.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.4.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.4.12. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Category (2017-2030)

14.4.13.2. Market Revenue and Forecast, by Types (2017-2030)

14.4.13.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.4.13.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.4.13.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.4.13.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Category (2017-2030)

14.4.14.2. Market Revenue and Forecast, by Types (2017-2030)

14.4.14.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.4.14.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.4.14.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.4.14.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Category (2017-2030)

14.5.2. Market Revenue and Forecast, by Types (2017-2030)

14.5.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.5.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.5.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.5.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Category (2017-2030)

14.5.7.2. Market Revenue and Forecast, by Types (2017-2030)

14.5.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.5.7.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.5.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.5.8.1. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Category (2017-2030)

14.5.9.2. Market Revenue and Forecast, by Types (2017-2030)

14.5.9.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.5.9.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.5.9.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.5.9.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

Chapter 15. Company Profiles

15.1. Nestlé (Gerber Products Company)

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Danone S.A.

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Reckitt Benckiser (Mead Johnson & Company, LLC)

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Abbott

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Feihe International Inc.

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Fries land Campina

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Bellamy's Organic

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Kraft Heinz

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. HiPP GmbH & Co. Vertrieb KG

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Perrigo

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

15.11. Arla Food

15.11.1. Company Overview

15.11.2. Product Offerings

15.11.3. Financial Performance

15.11.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments